Park Joo-Woong, Lee Joo-Kyung, Kwon Tae-Jong, Yi Dong-Hee, Kim Young-Jun, Moon Seong-Hoon, Suh Hyun-Hyo, Kang Sang-Mo, Park Yong-Il
Biotechnology Laboratory, Youngjin Pharmaceutical Co. Ltd., Pyungtaek-Si 451-860, Korea.
Biotechnol Lett. 2003 Nov;25(21):1827-31. doi: 10.1023/a:1026281914301.
Streptomyces sp. Y-110, isolated from soil, modified compactin to pravastatin, a therapeutic agent for hypercholesterolemia. In a batch culture, the highest production of pravastatin was 340 mg l(-1) from 750 mg compactin l(-1) in 24 h. By intermittent feeding of compactin into the culture medium, both the compactin concentration and its conversion increased to 2000 mg l(-1) and 1000 mg pravastatin l(-1), respectively, with the conversion rate of 10 mg l(-1) h(-1). Continuous feeding of compactin increased production of pravastatin to 15 mg l(-1) h(-1).
从土壤中分离得到的链霉菌属菌株Y-110可将美伐他汀转化为普伐他汀,后者是一种用于治疗高胆固醇血症的药物。在分批培养中,24小时内从750 mg/L美伐他汀中产生的普伐他汀最高产量为340 mg/L。通过向培养基中间歇补料美伐他汀,美伐他汀浓度及其转化率分别提高到2000 mg/L和1000 mg/L普伐他汀,转化率为10 mg/(L·h)。连续补料美伐他汀可使普伐他汀产量提高到15 mg/(L·h)。